Airway Microbiome of Patients With Protracted Bacterial Bronchitis

NCT07255430 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2026-03-19

No results posted yet for this study

Summary

This project aims to assess the relationship between the microbiome and virome composition, the immune responses, and the respiratory health of children with protracted bacterial bronchitis (PBB). In addition, we aim to evaluate how the standard treatment with azithromycin interacts with the components of the microbiome, virome and immune biomarkers.

Conditions

  • Protracted Bacterial Bronchitis

Sponsors & Collaborators

  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Kim Van Hoorenbeeck, Prof. dr. · University Hospital, Antwerp

  • Irina Spacova, Prof. dr. ir. · Universiteit Antwerpen

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-07
Primary Completion
2028-01-31
Completion
2029-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07255430 on ClinicalTrials.gov